资讯

Anthraquinone compound Kanglexin investigated for treatment of atherosclerosis
In conclusion, KLX exhibits protective effects against EndMT and atherosclerosis by activating the FGFR1/MAP4K4 pathway and suppressing the integrin β1/TGFβ signaling pathway. This study's ...
News Medical on MSN2 个月
KLX mitigates atherosclerotic progression by preventing EndMT
In conclusion, KLX exhibits protective effects against EndMT and atherosclerosis by activating the FGFR1/MAP4K4 pathway and suppressing the integrin β1/TGFβ signaling pathway. This study's ...